TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) › Shareholders' EquityTEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2007: $13.86B2008: $16.44B2009: $19.26B2010: $22.00B2011: $22.34B2012: $22.87B2013: $22.64B2016: $34.99B2017: $18.75B2018: $15.79B2019: $15.06B2020: $11.06B2021: $11.24B2022: $8.60B2023: $8.13B2024: $5.38B2025: $7.91B$7.91B2007Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$7.91B+47.1%2024$5.38B-33.8%2023$8.13B-5.5%2022$8.60B-23.5%2021$11.24B+1.7%2020$11.06B-26.6%2019$15.06B-4.6%2018$15.79B-15.7%2017$18.75B-46.4%2016$34.99B—2013$22.64B-1.0%2012$22.87B+2.3%2011$22.34B+1.5%2010$22.00B+14.2%2009$19.26B+17.2%2008$16.44B+18.6%2007$13.86B—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share